XTL Biopharmaceuticals Stock (NASDAQ: XTLB) stock price, news, charts, stock research, profile.
Open | $2.26 |
Close | $2.30 |
Volume / Avg. | 7.22K / 40.24K |
Day Range | 2.21 - 2.30 |
52 Wk Range | 0.75 - 4.99 |
Market Cap | $12.53M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of XTL Biopharmaceuticals (NASDAQ:XTLB) through any online brokerage.
Other companies in XTL Biopharmaceuticals’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Monopar Therapeutics (NASDAQ:MNPR).
There is no analysis for XTL Biopharmaceuticals.
There is no analysis for XTL Biopharmaceuticals to provide a consensus price target.
The stock price for XTL Biopharmaceuticals (NASDAQ: XTLB) is $2.3 last updated July 3, 2024 at 12:57 PM EDT.
There are no upcoming dividends for XTL Biopharmaceuticals.
XTL Biopharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 20, 2024.
There is no upcoming split for XTL Biopharmaceuticals.
XTL Biopharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.